Clinical trials

Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.

1,114 studies match

clinicaltrialsPublishedShowing 51–100 of 1,114 studies · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06863272	A Clinical Study of Ifinatamab Deruxtecan Based Treatment Combinations or as Monotherapy to Treat Metastatic Castrate Resistant Prostate Cancer (mCRPC) (MK-2400-01A/IDeate-Prostate02)	recruiting	Phase 1 / Phase 2	360	Merck Sharp & Dohme LLCINDUSTRY	19	Sep 17, 2026	clinicaltrials
NCT06941272	A Study of Patritumab Deruxtecan in Pediatric Participants With Relapsed or Refractory Solid Tumors (MK-9999-01C/LIGHTBEAM-U01)	recruiting	Phase 1 / Phase 2	50	Merck Sharp & Dohme LLCINDUSTRY	23	Sep 17, 2026